RIGVIR® is registered by the State Agency of Medicines of the Republic of Latvia, becoming the first approved oncolytic virotherapy medication.
Rigvir Group
Address: Atlasa street 7C, Riga, Latvia, LV-1026
Phone: +371 67 716 132
E-mail: pr@rigvir.com